Basis: Trailing twelve months (TTM). Source: stored company filings and market data; unavailable inputs remain N/A.
The enterprise value (EV) is $4.85B.
ENTERPRISE VALUE (EV)
$4.85B
Mirum Pharmaceuticals, Inc.
Market Cap
$4.83B
Enterprise Value (EV)
$4.85B
| NAME | MARKET CAP | ENTERPRISE VALUE (EV) |
|---|---|---|
| Mirum Pharmaceuticals, Inc. (MIRM) | $4.83B | $4.85B |
| Oruka Therapeutics, Inc. (ORKA)vs › | $4.84B | $4.57B |
| Dianthus Therapeutics, Inc. (DNTH)vs › | $4.78B | $4.67B |
| Definium Therapeutics, Inc. (DFTX)vs › | $4.73B | $4.11B |
| Erasca, Inc. (ERAS)vs › | $4.96B | $4.97B |
| LifeStance Health Group, Inc. (LFST)vs › | $4.70B | $4.68B |
| Option Care Health, Inc. (OPCH)vs › | $4.64B | $5.72B |
| Waystar Holding Corp. (WAY)vs › | $5.06B | $6.53B |
| BillionToOne, Inc. (BLLN)vs › | $4.60B | $4.19B |
| Merit Medical Systems, Inc. (MMSI)vs › | $5.07B | $5.44B |
Market Cap
$4.83B
Total Debt
$309.80M
Cash
$296.68M
Enterprise Value
$4.85B
Why use EV instead of Market Cap?
Enterprise Value represents the total value of a company as if you were to acquire it completely - paying for equity while assuming debt and receiving cash.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
